Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints (Q3435673): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Normalize DOI. |
||
(3 intermediate revisions by 3 users not shown) | |||
Property / DOI | |||
Property / DOI: 10.1111/j.0006-341X.2004.00146.x / rank | |||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Q3999494 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Q3747485 / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis / rank | |||
Normal rank | |||
Property / cites work | |||
Property / cites work: Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis / rank | |||
Normal rank | |||
Property / Wikidata QID | |||
Property / Wikidata QID: Q44806501 / rank | |||
Normal rank | |||
Property / DOI | |||
Property / DOI: 10.1111/J.0006-341X.2004.00146.X / rank | |||
Normal rank |
Latest revision as of 06:53, 21 December 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints |
scientific article |
Statements
Design and Analysis of Group Sequential Clinical Trials with Multiple Primary Endpoints (English)
0 references
7 May 2007
0 references
alpha-spending function
0 references
beta-spending function
0 references
multivariate outcomes
0 references
sample size
0 references
time-to-event data
0 references